|
|
|
Insider
Information: |
Bird Jeffrey W |
Relationship: |
Director, 10% Owner |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
8,735,679 |
|
Indirect Shares
|
2,993,315 |
|
|
Direct
Value |
$168,211,378 |
|
|
Indirect Value
|
$16,283,158 |
|
|
Total
Shares |
11,728,994 |
|
|
Total
Value |
$184,494,536 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
498.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mattersight Corporation |
MATR |
10% Owner |
2003-09-26 |
0 |
2017-06-01 |
1,128,034 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director, 10% Owner |
2012-03-29 |
5,316,967 |
2011-10-21 |
229,567 |
Premium* |
|
Dextera Surgical Inc |
DXTR |
Director, 10% Owner |
2013-03-20 |
3,412,793 |
2013-03-20 |
170,977 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
Director |
2017-06-01 |
919 |
2017-06-01 |
377,782 |
Premium* |
|
Quinstreet, Inc |
QNST |
10% Owner |
|
0 |
2010-02-10 |
1,114 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director |
2013-12-13 |
5,000 |
2013-12-13 |
178,406 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2020-07-02 |
0 |
Premium* |
|
Yext Inc |
YEXT |
10% Owner |
|
0 |
2017-12-01 |
724,841 |
Premium* |
|
Venus Concept Inc |
VERO |
Director, 10% Owner |
2017-10-16 |
0 |
2017-10-16 |
182,594 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-30 |
4 |
B |
$8.32 |
$127,595 |
I/I |
15,333 |
24,554 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-27 |
4 |
B |
$7.53 |
$138,587 |
I/I |
18,413 |
23,635 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-21 |
4 |
B |
$6.76 |
$155,480 |
I/I |
23,000 |
22,041 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-12 |
4 |
B |
$6.45 |
$185,783 |
I/I |
28,791 |
20,052 |
1.5 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2013-12-13 |
4/A |
B |
$6.50 |
$208,488 |
I/I |
32,075 |
178,406 |
2.66 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2007-08-15 |
4 |
B |
$14.10 |
$270,241 |
I/I |
19,166 |
1,549,407 |
1.5 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2017-06-01 |
4 |
B |
$0.57 |
$289,773 |
I/I |
510,703 |
377,782 |
2.1 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2008-05-23 |
4 |
B |
$7.03 |
$301,904 |
I/I |
42,950 |
23,157 |
1.5 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2007-08-17 |
4 |
B |
$2.10 |
$341,777 |
I/I |
162,751 |
11,650 |
1.5 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2009-02-06 |
4 |
B |
$0.69 |
$356,620 |
I/I |
519,097 |
105,402 |
1.5 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2020-07-02 |
4 |
D |
$18.00 |
$368,550 |
D/D |
(20,475) |
0 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2006-12-15 |
4 |
B |
$1.00 |
$384,450 |
I/I |
384,450 |
8,515 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2004-12-15 |
4 |
B |
$6.00 |
$397,962 |
I/I |
66,327 |
4,600 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2007-11-14 |
4 |
B |
$13.05 |
$770,381 |
I/I |
59,033 |
1,651,054 |
1.5 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2017-06-01 |
4 |
B |
$3.65 |
$801,868 |
I/I |
219,732 |
1,056,194 |
1.5 |
- |
|
CORT |
Corcept Therapeutics Inc |
10% Owner |
|
2007-03-30 |
4 |
B |
$1.00 |
$818,145 |
I/I |
818,145 |
11,117 |
1.5 |
- |
|
VERO |
Venus Concept Inc |
Director |
|
2017-10-16 |
4 |
A |
$0.00 |
$828,135 |
I/I |
2,334,913 |
182,594 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2012-03-29 |
4 |
OE |
$2.96 |
$829,880 |
D/D |
280,365 |
5,316,967 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-10-01 |
4 |
S |
$3.77 |
$899,697 |
I/I |
(238,520) |
244,146 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2014-10-01 |
4 |
OE |
$2.05 |
$899,702 |
I/I |
438,879 |
256,009 |
0 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2013-12-03 |
4 |
B |
$3.90 |
$918,840 |
I/I |
235,600 |
22,081 |
1.5 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2013-11-21 |
4 |
B |
$6.24 |
$942,251 |
I/I |
151,089 |
46,419 |
2.1 |
- |
|
DXTR |
Dextera Surgical Inc |
Director |
|
2013-03-20 |
4 |
B |
$1.05 |
$1,030,823 |
D/D |
981,736 |
3,412,793 |
3.92 |
- |
|
MATR |
Mattersight Corporation |
10% Owner |
|
2012-09-04 |
4 |
B |
$5.40 |
$1,051,737 |
I/I |
194,640 |
12,327 |
2.64 |
- |
|
DXTR |
Dextera Surgical Inc |
10% Owner |
|
2013-03-20 |
4 |
B |
$1.05 |
$1,070,897 |
I/I |
1,019,902 |
136,623 |
1.5 |
- |
|
143 Records found
|
|
Page 5 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|